Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Other Current Liabilities
Mayinglong Pharmaceutical Group Co Ltd
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Other Current Liabilities
¥194m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Current Liabilities
¥530.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Current Liabilities
¥450.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Current Liabilities
¥721.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
9%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Current Liabilities
¥3.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Other Current Liabilities
¥101.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Other Current Liabilities?
Other Current Liabilities
194m
CNY
Based on the financial report for Mar 31, 2024, Mayinglong Pharmaceutical Group Co Ltd's Other Current Liabilities amounts to 194m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-2%
Over the last year, the Other Current Liabilities growth was -33%. The average annual Other Current Liabilities growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -19% over the past three years , -7% over the past five years , and -2% over the past ten years .